Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

2.2K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.2K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

863
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
863
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

524
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
524
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

1.2K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.2K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

1.3K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.3K
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

710
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
710

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health systems science education for undergraduate medical students: a 3-year longitudinal curriculum preparing students to drive real-world health system improvement.

BMC medical education·2026
Same author

Acute upper gastrointestinal bleeding in the UK: 2022 audit update.

Gut·2025
Same author

A values-driven academic affiliation between a public medical school and a private healthcare provider: exploring the perceptions of key opinion leaders.

Frontiers in health services·2025
Same author

Investigating the learning value of early clinical exposure among undergraduate medical students in Dubai: a convergent mixed methods study.

BMC medical education·2025
Same author

Effects of building resilience skills among undergraduate medical students in a multi-cultural, multi-ethnic setting in the United Arab Emirates: A convergent mixed methods study.

PloS one·2025
Same author

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.

Nature medicine·2025

Related Experiment Video

Updated: Feb 8, 2026

Mouse Model of Pressure Ulcers After Spinal Cord Injury
06:51

Mouse Model of Pressure Ulcers After Spinal Cord Injury

Published on: March 9, 2019

10.1K

Endotherapy of Peptic Ulcer Bleeding.

Debbie Troland1, Adrian Stanley1

  • 1Gastrointestinal Unit, Glasgow Royal Infirmary, Walton Building, Castle Street, Glasgow G4 0SF, UK.

Gastrointestinal Endoscopy Clinics of North America
|June 24, 2018
PubMed
Summary

Peptic ulcer bleeding management is crucial due to high morbidity. This review covers endoscopic assessment and therapies for optimal treatment of peptic ulcers.

Keywords:
Duodenal ulcerEndoscopic therapyGastric ulcerNonvariceal upper GI hemorrhagePeptic ulcerPeptic ulcer bleeding

More Related Videos

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

1.6K
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.5K

Related Experiment Videos

Last Updated: Feb 8, 2026

Mouse Model of Pressure Ulcers After Spinal Cord Injury
06:51

Mouse Model of Pressure Ulcers After Spinal Cord Injury

Published on: March 9, 2019

10.1K
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

1.6K
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.5K

Area of Science:

  • Gastroenterology
  • Endoscopy
  • Internal Medicine

Background:

  • Peptic ulcer bleeding is a frequent gastrointestinal emergency.
  • It is associated with substantial patient morbidity and mortality.
  • Effective management strategies are essential for improving patient outcomes.

Purpose of the Study:

  • To review the endoscopic assessment of peptic ulcers.
  • To discuss the rationale behind treatment decisions for peptic ulcer bleeding.
  • To evaluate the evidence for various endoscopic therapies and determine optimal management.

Main Methods:

  • Literature review of endoscopic assessment techniques.
  • Analysis of treatment guidelines and clinical evidence.
  • Synthesis of data on endoscopic hemostasis therapies.

Main Results:

  • Endoscopic evaluation is key to stratifying bleeding risk.
  • Multiple endoscopic therapies exist, including injection, thermal, and mechanical methods.
  • Combination therapies may offer superior hemostasis in high-risk ulcers.

Conclusions:

  • Optimal endoscopic management of peptic ulcer bleeding involves accurate assessment followed by appropriate therapeutic intervention.
  • Evidence supports the use of specific endoscopic techniques based on ulcer characteristics.
  • Further research may refine combination therapy protocols for refractory cases.